US Patent Issued to Medtronic on Dec. 30 for "Therapy programming based on evoked compound action potentials" (Minnesota, Wisconsin, California Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,433, issued on Dec. 30, was assigned to Medtronic Inc. (Minneapolis).

"Therapy programming based on evoked compound action potentials" was invented by Andrew L. Schmeling (Holmen, Wis.), David A. Dinsmoor (North Oaks, Minn.), Hank T. Bink (Golden Valley, Minn.), Kristin N. Hageman (Dayton, Minn.), Rebecca A. Miron (Center City, Minn.), Christopher J. Edwards (Mahtomedi, Minn.), David W. Simons (Edina, Minn.), Nikita Tandon (San Jose, Calif.) and Reid K. Bornhoft (Lino Lakes, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure is directed to devices, systems, and techniques for controlling electrical stimulation. In some examples, a ...